SS
TENX icon

SBI Securities’s Tenax Therapeutics TENX Stock Holding History

SBI Securities’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$829 Buy
+57
New +$728 ﹤0.01% 2868
2025
Q4 		– Sell
-2
Closed -$15 – 4218
2025
Q3 		$15 Buy
+2
New +$12 ﹤0.01% 3968
2025
Q1 		– Sell
-5
Closed -$31 – 4200
2024
Q4 		$31 Buy
+5
New +$24 ﹤0.01% 3743

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

SBI Securities's TENX Position: Q2 2026 in Review

SBI Securities opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 57 shares worth $829. The stake represents ﹤0.01% of the portfolio and ranks #2868 among its holdings. This is a return to the name: SBI Securities previously reported a position in TENX as recently as Q3 2025.

SBI Securities first reported a position in TENX in Q4 2024 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • SBI Securities held 57 shares of Tenax Therapeutics worth $829 as of Q2 2026.
  • Tenax Therapeutics was a new SBI Securities position in Q2 2026.
  • Tenax Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2868 holding.
  • SBI Securities first reported a position in Tenax Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.